Dr Habeebullah Life Sciences Ltd
BSE:539267
Dr Habeebullah Life Sciences Ltd
Dr Habeebullah Life Sciences Ltd. is an India-based company. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2015-08-10. The firm is engaged in research and development (R&D), trading, import and exports, and R&D services of bioproducts and pharma products. The firm's products and R&D include Stem Cell R&D, New Drug Discovery, ribonucleic acid (RNA) Interference, Molecular Biomarkers and Medical Devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology, stem cell and cord blood banking. Its New Drug Discovery division is focused on working on five therapeutic areas of Wilson’s disease, non-alcoholic steatohepatitis (NASH), neuropathic pain, cardiovascular diseases, cystinosis and Huntington's disease. Its services include molecular diagnostics, stem cell therapy, clinical services, contract research organization and academic services.
Dr Habeebullah Life Sciences Ltd. is an India-based company. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2015-08-10. The firm is engaged in research and development (R&D), trading, import and exports, and R&D services of bioproducts and pharma products. The firm's products and R&D include Stem Cell R&D, New Drug Discovery, ribonucleic acid (RNA) Interference, Molecular Biomarkers and Medical Devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology, stem cell and cord blood banking. Its New Drug Discovery division is focused on working on five therapeutic areas of Wilson’s disease, non-alcoholic steatohepatitis (NASH), neuropathic pain, cardiovascular diseases, cystinosis and Huntington's disease. Its services include molecular diagnostics, stem cell therapy, clinical services, contract research organization and academic services.
